
Wei Wu He
Description
Dr. He has been serving as Executive Chairman of Human Longevity Inc since July 2019. Prior to HLI, Dr. He was the CEO of OriGene Technologi...
Investor Profile
Wei Wu He has made 1 investments, with 1 in the past 12 months and 0% as lead.
Stage Focus
- Post Ipo Equity (100%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Medical
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.